0001104659-21-020193.txt : 20210211 0001104659-21-020193.hdr.sgml : 20210211 20210211063523 ACCESSION NUMBER: 0001104659-21-020193 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210210 FILED AS OF DATE: 20210211 DATE AS OF CHANGE: 20210211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Akers Joseph A CENTRAL INDEX KEY: 0001379888 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13341 FILM NUMBER: 21616593 MAIL ADDRESS: STREET 1: 630 FIFTH AVENUE, 22ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10111 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TITAN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000910267 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943171940 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 OYSTER POINT BLVD STREET 2: SUITE 505 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6502444990 MAIL ADDRESS: STREET 1: 400 OYSTER POINT BLVD STREET 2: SUITE 505 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 4 1 tm216217-2_4.xml OWNERSHIP DOCUMENT X0306 4 2021-02-10 0 0000910267 TITAN PHARMACEUTICALS INC TTNP 0001379888 Akers Joseph A 102 W. GLENHAVEN DRIVE PHOENIX AZ 85045 1 0 0 0 Option to Purchase Common Stock 4.02 2021-02-10 4 A 0 25000 0 A 2021-08-10 2031-02-10 Common Stock 25000 25000 D /S/ Joseph A. Akers 2021-02-10